ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026
Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.
Albert Wolkerstorfer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.